MedGen Inc (MDIN)

[imjtw2u]

look at the bottom. 2009.....


NEW PRODUCT by CACI
SNORenz

Finally we are on the verge of launching our new product: SNOR-ENZ! This product was sold throughout the US
and Europe and is being revived by our Company. It will add significant
revenue to our bottom line and was the industry leader several years ago. There is nothing in the market that can
compete with the product and our commercial launch is imminent.


NEWS OUT!!!!!

Cross Atlantic Commodities, Inc. (CXAC.PK), a successful manufacturer of specialty health and beauty products, announced signing a distribution agreement with the holders of the Snorenz patent. Snorenz(R) is a nationally well known snoring product.

"We have done our homework on Snorenz(R) and are very excited about the research that the previous company has done and the size of the snoring category", states Jorge Bravo President / CEO. In 2002, the Company completed a double blind study at Northwestern Hospital's Sleep Center in Atlanta, GA, under the direction of Dr. Samuel Mickelson of the Advanced Ear Nose and Throat P.C. The results of that study concluded that SNORenz(R) is an effective product to reduce the noise associated with snoring. We will begin marketing Snorenz, first through Online Marketing, Pay Per Search and Affiliate Marketing Programs. Within the next few weeks our new Snorenz website will be live.



http://crossac.com/


Florida Atlantic Stock Transfer Inc.
7130 Nob Hill Road
Tamarac, FL 33321
last TA update, September 24th, 2009
Authorized Shares (AS) = 6,500,000,000
Outstanding Shares (OS) = 6,499,953,268

Sept 28 2009 Filing for CXAC

http://pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=24648